RVNC Revance Therapeutics Inc.

$29.45 -3.76%

269,404 Shares Traded
363,078 Average Volume (last 30 days)

as of March 23, 2018 EST IEX Real-Time Price

Short Pain Metrics

Approximate Amount of Money Shorts Have Made on the Day: $2.4 million
If Intiated on the First, Shorts Have Realized a Year to Date Return of:18.18%
If Intiated One Month Ago, Shorts Have Realized a Return of:-1.16%
If Initiated Five Days ago, Shorts Have Realized a Return of:1.29%
Peer Potential Short Squeezes Near Real Time Screener
*Please note the actual returns of shorts could be different as they started from different points

Daily Indicators

Daily Short Pain Indicator [i] - Always Use Fundamentals on EverythingNeutral
200 Day Moving Average Indicator Bullish
50 Day Moving Average Indicator Bearish
52 Week High/Low Indicator Neutral

Short Stats

Short Percent to Float 5.77%
Short Interest2.09 million
Float36.2 million
Short Ratio8.32
Market Cap$1.12 billion
Market Maker ActivityDaily Short Volume


Revance to Participate in the Needham Healthcare Conference (Business Wire)
Desperate Allergan Seeks 'Sense Of Urgency' (SeekingAlpha)
Revance to Participate in Upcoming Investor Conferences (Business Wire)
Premarket analyst action - healthcare (SeekingAlpha)
Your Daily Pharma Scoop: Portola Drops On AndexXa Update, NovaVax Top-Line Results, Idera Commences Late-Stage Study With IMO-2125 (SeekingAlpha)
Allergan: Botox Biosimilar From Mylan And Revance Sounds Ominous (SeekingAlpha)
Revance Therapeutics' (RVNC) CEO Dan Browne on Q4 2017 Results - Earnings Call Transcript (SeekingAlpha)
Mylan teams up with Revance to develop Botox biosimilar (SeekingAlpha)
Revance Therapeutics misses by $0.17, misses on revenue (SeekingAlpha)
Revance Releases Fourth Quarter and Full Year 2017 Results (Business Wire)

Smart Money Sentiment

Institutional Ownership (Top 15 Funds) 84.7%

Earnings Stats

PE Ratio -7.36
Dividend Yield 0%
Peer EarningsEarnings Calendar


200 Day Moving Average $27.96
50 Day Moving Average $32.01
52 Week High $37.45
52 Week Low $18.43

Data provided for free by IEX. Questions? Read the FAQ